<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02503449</url>
  </required_header>
  <id_info>
    <org_study_id>LYN-316</org_study_id>
    <nct_id>NCT02503449</nct_id>
  </id_info>
  <brief_title>Clinical Trial of Pulmonary Cryptococcosis in China</brief_title>
  <acronym>MCTOPCIC</acronym>
  <official_title>Multi-center Clinical Trial of Pulmonary Cryptococcosis in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhixin Liang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Medical University General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Hospital of China Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huadong Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanjing PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fuzhou General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangzhou Institute of Respiratory Disease</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan TongJi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Science Center of Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guizhou Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenyang Military General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Hospital of Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fujian Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fuzhou Pulmonary Hospital of Fujian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Nanchang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Longyan City First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study:1.Improve the understanding of the risk factors of pulmonary&#xD;
      cryptococcosis;2.Improve the awareness of pulmonary cryptococcosis clinical and imaging&#xD;
      manifestations;3.Grasp pulmonary cryptococcosis patients of clinical and imaging&#xD;
      manifestations in different conditions;4.Learn about antibacterial activity of antifungal&#xD;
      drugs for cryptococcosis in China.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Patients corresponding to inclusion criteria and obtaining informed consent are included&#xD;
           in the research in department of respiration ward in cooperative hospitals.&#xD;
&#xD;
        2. Relevant case report forms are created in this study.&#xD;
&#xD;
        3. Basic information such as age,weight and height is recorded in selected cases.Clinical&#xD;
           manifestations,risk factors,laboratory examination,imaging examination,etiological&#xD;
           examination and histopathological examination are also recorded in selected cases by&#xD;
           case report forms.In addition,antifungal treatment is recorded including name,dose,time&#xD;
           of starting treatment and terminate treatment.Causes of terminate treatment and curative&#xD;
           effect evaluation should be analysed.&#xD;
&#xD;
        4. Statistical analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>differences in clinical manifestations of pulmonary cryptococcosis</measure>
    <time_frame>30 days</time_frame>
    <description>Methods including laboratory examination(routine blood test),imaging examination(chest CT),scoring system(APACHE II score)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>treatment of pulmonary cryptococcosis</measure>
    <time_frame>30 days</time_frame>
    <description>Efficacy as measured by recording dose and time of therapy for antifungal agents</description>
  </secondary_outcome>
  <enrollment type="Actual">260</enrollment>
  <condition>Cryptococcosis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      sputum,whole blood,pleural effusion,lung tissue,cerebrospinal fluid,fungus(smear&#xD;
      examination,culture and identification,antigen detection,drug sensitive test)&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1. Improve the understanding of the risk factors of pulmonary cryptococcosis.&#xD;
&#xD;
          2. Improve the awareness of pulmonary cryptococcosis clinical and imaging manifestations.&#xD;
&#xD;
          3. Grasp pulmonary cryptococcosis patients of clinical and imaging manifestations in&#xD;
             different conditions.&#xD;
&#xD;
          4. Learn about antibacterial activity of antifungal drugs for cryptococcosis in China.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients possess clinical or imaging manifestations of pulmonary infections,with any of the&#xD;
        results(by one of following conditions) by microbiological examination or histopathologic&#xD;
        examination&#xD;
&#xD;
          1. Cryptococcal capsular polysaccharide antigen of blood or pleural effusion is positive&#xD;
&#xD;
          2. Cryptococcus（fungus culture) is discovered by lower respiratory tract specimens&#xD;
&#xD;
          3. Cryptococcus（pleural effusions culture) is discovered by pleural effusions collected&#xD;
             under sterile condition&#xD;
&#xD;
          4. Cryptococcus（pus culture) is discovered by pus smear out of pulmonary infections in&#xD;
             disseminated infection patients&#xD;
&#xD;
          5. Cryptococcus（blood culture) is discovered by microscopy of specimens of blood smear&#xD;
&#xD;
          6. Cryptococcus is discovered by culturing of the pathological tissue specimens in&#xD;
             aseptic condition&#xD;
&#xD;
          7. Cryptococcal capsular budding yeast with inflammatory reaction is discovered by&#xD;
             histopathological examination,cell pathology examination or microscopic examination in&#xD;
             aseptic condition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients suffer from acquired immune deficiency syndrome&#xD;
&#xD;
          2. Patients or their legal guardians request to withdraw the clinical research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhixin Liang, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhen Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Chao Yang Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yanming Li</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ministry of Health, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lina Sun</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jie Cao</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tianjin Medical University General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yunzhuo Chu</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Hospital of China Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhijie Zhang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shengjing Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yufen Jin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Hospital of Jilin University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiaobin Ma</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shandong Provincial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yanping Zhu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huadong Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xin Su</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nanjing PLA General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guoxiang Lai</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fuzhou General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Feng Ye</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guangzhou Institute of Respiratory Disease</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shengdao Xiong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wuhan TongJi Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lan Yang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Health Science Center of Xi'an Jiaotong University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hong Yu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guizhou Provincial People's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>wencheng Xue</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shenyang Military General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yadong Yuan</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Second Hospital of Hebei Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chengping Hu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xiangya Hospital of Central South University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Baosong Xie</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fujian Provincial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiaohong Chen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fuzhou Pulmonary Hospital of Fujian</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiangdong Zhou</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southwest Hospital, China</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wenjiang Ma</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Zhejiang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yuping Li</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hongni Jiang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Zhongshan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wei Bai</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital of Nanchang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sucheng Zhong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Longyan City First Hospital</affiliation>
  </overall_official>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>December 28, 2014</study_first_submitted>
  <study_first_submitted_qc>July 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2015</study_first_posted>
  <last_update_submitted>July 17, 2015</last_update_submitted>
  <last_update_submitted_qc>July 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Zhixin Liang</investigator_full_name>
    <investigator_title>Chinese Medical Association of respiratory diseases</investigator_title>
  </responsible_party>
  <keyword>Pulmonary Cryptococcosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cryptococcosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

